Intralesional treatment of metastatic melanoma: a review of therapeutic options.
about
Tumor-related interleukins: old validated targets for new anti-cancer drug development.Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis.Microradiopharmaceutical for Metastatic Melanoma.Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab.Intratumoral administration of IL2- and TNF-based fusion proteins cures cancer without establishing protective immunity.Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
P2860
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@en
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@nl
type
label
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@en
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@nl
prefLabel
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@en
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@nl
P2860
P1476
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
@en
P2093
Benjamin Weide
P2860
P2888
P304
P356
10.1007/S00262-016-1952-0
P577
2017-01-11T00:00:00Z